← Leaderboards
William W Hauswirth
University Of Florida
$34,023,360
Attributed
$41,401,129
Total exposure
11
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.2M · FY2005–22$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$43,898,713 · 12
By mechanism
R24$17,632,017 · 3
U10$11,467,428 · 1
P30$6,536,647 · 3
R01$3,668,736 · 1
P01$2,430,382 · 1
T32$1,349,357 · 1
Top collaborators
- Stylianos Michalakis6 shared
- Simon Petersen-Jones6 shared
- Stephen H Tsang6 shared
- Alan Horsager2 shared
- John R Guy1 shared
- Martha D. Neuringer1 shared
Most similar at University Of Florida
Same institution · by research overlap
- John R Guy$21,490,889
- Shannon Elizabeth Boye$7,910,294
- Cynthia C Lord$3,117,287
- Susan Lynn Semple-Rowland$2,994,898
- Amy Yomiko Vittor$2,166,391
Others in their field
Top investigators on “Gene Therapy”
- David Heimbrook · Leidos Biomedical Research, Inc.$164,199,916
- Gregory H Reaman · National Childhood Cancer Foundation$155,841,493
- Randall J Bateman · Washington University$122,781,098
- Eric Martin McDade · Washington University$94,632,845
- Ronald G Crystal · Weill Medical College Of Cornell Univ$82,649,124
- Robert B. Diasio · University Of Alabama At Birmingham$73,470,685
Research focus
Gene TherapyVisionGenesRetinaVectorResearch PersonnelGene ExpressionAdeno-Associated Viral VectorMutationTransfection /Expression VectorFundingClinical TrialsLaboratory MouseRetinitis PigmentosaMutantGenetically Modified AnimalsLinkMeetingsRattusElectroretinographyBlindnessRhodopsinReporter GenesRetinal Degeneration
Grant awards (68)
Translational Gene Therapy for CNGB1 Retinitis Pigmentosa$1,517,749
R24 · FY2022 · EY
Translational Gene Therapy for CNGB1 Retinitis Pigmentosa$1,828,029
R24 · FY2021 · EY
Translational Gene Therapy for CNGB1 Retinitis Pigmentosa$363,550
R24 · FY2021 · EY
Translational Gene Therapy for CNGB1 Retinitis Pigmentosa$1,832,126
R24 · FY2020 · EY
Translational Gene Therapy for CNGB1 Retinitis Pigmentosa$1,783,428
R24 · FY2019 · EY
Mito-Targeted AAV to treat Leber Hereditary Optic Neuropathy caused by ND4 mutations$1,124,711
R24 · FY2019 · EY
Translational Gene Therapy for CNGB1 Retinitis Pigmentosa$1,253,534
R24 · FY2018 · EY
rAAV-CNGB3 Gene Therapy for Achromatopsia: Translational Research Studies$1,613,805
R24 · FY2017 · EY · contact PI
rAAV-CNGB3 Gene Therapy for Achromatopsia: Translational Research Studies$1,663,014
R24 · FY2016 · EY · contact PI
rAAV-CNGB3 Gene Therapy for Achromatopsia: Translational Research Studies$1,298,215
R24 · FY2015 · EY · contact PI
Vision Research Core$560,124
P30 · FY2015 · EY · contact PI
rAAV-CNGB3 Gene Therapy for Achromatopsia: Translational Research Studies$1,707,387
R24 · FY2014 · EY · contact PI
Vision Research Core$560,124
P30 · FY2014 · EY · contact PI
rAAV-CNGB3 Gene Therapy for Achromatopsia: Translational Research Studies$1,646,469
R24 · FY2013 · EY · contact PI
Vision Research Core$560,124
P30 · FY2013 · EY · contact PI
Vision Research Core$560,124
P30 · FY2012 · EY · contact PI
Vision Research Core$576,275
P30 · FY2011 · EY · contact PI
VISION RESEARCH CORE$199,999
P30 · FY2010 · EY · contact PI
Establishing channelrhodopsin as a tool to restore visual function$86,311
R43 · FY2010 · EY
VISION RESEARCH CORE$599,384
P30 · FY2009 · EY · contact PI
Retinal Gene Delivery by Adeno-Associated Virus$441,707
R01 · FY2009 · EY · contact PI
Establishing channelrhodopsin as a tool to restore visual function$301,989
R43 · FY2009 · EY
CORE--MOLECULAR GENETICS$167,709
P30 · FY2009 · EY · contact PI
VISION RESEARCH CORE$582,402
P30 · FY2008 · EY · contact PI
Retinal Gene Delivery by Adeno-Associated Virus$423,529
R01 · FY2008 · EY · contact PI
Glial derived neurotrophic factor and ribozymes for retinitis pigmentosa$281,140
P01 · FY2008 · NS · contact PI
Research Training in Vision Science$176,061
T32 · FY2008 · EY · contact PI
CORE--MOLECULAR GENETICS$162,957
P30 · FY2008 · EY · contact PI
VISION RESEARCH CORE$565,906
P30 · FY2007 · EY · contact PI
Retinal Gene Delivery by Adeno-Associated Virus$418,995
R01 · FY2007 · EY · contact PI
Glial derived neurotrophic factor and ribozymes for retinitis pigmentosa$284,806
P01 · FY2007 · NS · contact PI
CORE--MOLECULAR GENETICS$158,342
P30 · FY2007 · EY · contact PI
Research Training in Vision Science$123,052
T32 · FY2007 · EY · contact PI
VISION RESEARCH CORE$549,893
P30 · FY2006 · EY · contact PI
Retinal Gene Delivery by Adeno-Associated Virus$410,434
R01 · FY2006 · EY · contact PI
GDNF and ribozymes for retinitis pigmentosa$280,667
P01 · FY2006 · NS · contact PI
CORE--MOLECULAR GENETICS$144,116
P30 · FY2006 · EY · contact PI
Research Training in Vision Science$92,720
T32 · FY2006 · EY · contact PI
Gene Therapy for Leber Congenital Amaurosis$2,144,684
U10 · FY2005 · EY
Retinal Gene Delivery by Adeno-Associated Virus$451,329
R01 · FY2005 · EY
GDNF and ribozymes for retinitis pigmentosa$273,220
P01 · FY2005 · NS
Research Training in Vision Science$197,778
T32 · FY2005 · EY
CORE--MOLECULAR GENETICS$159,640
P30 · FY2005 · EY
Gene Therapy for Leber Congenital Amaurosis$2,718,463
U10 · FY2004 · EY
GDNF and ribozymes for retinitis pigmentosa$279,535
P01 · FY2004 · NS
RETINAL GENE DELIVERY BY ADENO-ASSOCIATED VIRUS$266,281
R01 · FY2004 · EY
Research Training in Vision Science$197,778
T32 · FY2004 · EY
Gene Therapy for Leber Congenital Amaurosis$2,471,068
U10 · FY2003 · EY
RETINAL GENE DELIVERY BY ADENO-ASSOCIATED VIRUS$266,281
R01 · FY2003 · EY
RESEARCH TRAINING IN VISION SCIENCE$179,229
T32 · FY2003 · EY
Gene Therapy for Leber Congenital Amaurosis$1,972,424
U10 · FY2002 · EY
RETINAL GENE DELIVERY BY ADENO-ASSOCIATED VIRUS$266,281
R01 · FY2002 · EY
GENE THERAPY FOR AUTOSOMAL DOMINANT RETINITIS PIGMENTOSA$242,910
P01 · FY2002 · NS
RIBOZYME-MEDIATED IN VIVO PHOTORECEPTOR EXPRESSION$212,944
R21 · FY2002 · EY
RESEARCH TRAINING IN VISION SCIENCE$158,742
T32 · FY2002 · EY
CORE--MOLECULAR GENETICS$143,176
P30 · FY2002 · EY
Gene Therapy for Leber Congenital Amaurosis$2,160,789
U10 · FY2001 · EY
RETINAL GENE DELIVERY BY ADENO-ASSOCIATED VIRUS$446,493
R01 · FY2001 · EY
GENE THERAPY FOR AUTOSOMAL DOMINANT RETINITIS PIGMENTOSA$283,370
P01 · FY2001 · NS
RIBOZYME-MEDIATED IN VIVO PHOTORECEPTOR EXPRESSION$212,902
R21 · FY2001 · EY
RESEARCH TRAINING IN VISION SCIENCE$147,115
T32 · FY2001 · EY
CORE--MOLECULAR GENETICS$143,176
P30 · FY2001 · EY
GENE THERAPY FOR AUTOSOMAL DOMINANT RETINITIS PIGMENTOSA$0
P01 · FY2001 · NS
GENE THERAPY FOR AUTOSOMAL DOMINANT RETINITIS PIGMENTOSA$283,370
P01 · FY2000 · NS
RETINAL GENE DELIVERY BY ADENO-ASSOCIATED VIRUS$277,406
R01 · FY2000 · EY
GENE THERAPY FOR AUTOSOMAL DOMINANT RETINITIS PIGMENTOSA$221,364
P01 · FY2000 · NS
CORE--MOLECULAR GENETICS$143,176
P30 · FY2000 · EY
RESEARCH TRAINING IN VISION SCIENCE$76,882
T32 · FY2000 · EY